Page 4 - ஜவஹர்லால் நிறுவனம் ஆஃப் போஸ்ட்‌க்ர்யாஜுயேட் மருத்துவ கல்வி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜவஹர்லால் நிறுவனம் ஆஃப் போஸ்ட்‌க்ர்யாஜுயேட் மருத்துவ கல்வி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜவஹர்லால் நிறுவனம் ஆஃப் போஸ்ட்‌க்ர்யாஜுயேட் மருத்துவ கல்வி Today - Breaking & Trending Today

Postpone AIIMS INI CET 2021, demand aspirants: Here's why


Postpone AIIMS INI CET 2021, demand aspirants: Here s why
Thousands of aspirants who have registered for INI CET 2021 are demanding the postponement of the postgraduate entrance examination conducted by AIIMS.
advertisement
Postpone AIIMS INI CET 2021, demand medical aspirants
Doctors hoping to pursue postgraduate studies in medicine are demanding that the Institutes of National Importance Combined Entrance Test (INI CET 2021) be postponed. On May 27, the All India Institute of Medical Sciences (AIIMS) which conducts the entrance exam for postgraduate medicine, announced new dates for it. INI CET 2021 is now scheduled for June 16.
The exams have been scheduled on very short notice, while they are still working as front-line workers on Covid-19 duties, said AIIMS INI CET 2021 aspirant. ....

Gaurav Tyagi , Narendra Modi , National Eligibility , National Institute Of Mental Health , Institutes Of National Importance Combined Entrance Test , Jawaharlal Institute Of Postgraduate Medical Education , India Institute Of Medical Sciences , National Importance Combined Entrance Test , All India Institute , Medical Sciences , Jawaharlal Institute , Postgraduate Medical Education , National Institute , Mental Health , Entrance Test , Ini Cet , Aiims Ini Cet , Ini Cet 2021 , Iims Entrance Exam , Ini Cet Registration , Iimsexams Org , Ni Cet Postponemnet , Ostpone Ini Cet , Iims Pg Exam , Iims Pg Entrance Exam , Iims Ini Cet Updates ,

Should India reduce gap between Covishield doses based on UK vaccine efficacy data for new variant?


Members of India’s Covid Working Group don’t think so.
2 hours ago
A health worker prepares to administer a dose of the Covishield, AstraZeneca-Oxford s Covid-19 coronavirus vaccine, at a vaccination centre in Mumbai on April 1.
|
Punit Paranjpe / AFP
On May 13, when the Indian government increased the duration between two doses of the Covishield vaccine to 12 weeks-16 weeks from eight weeks-six weeks, it cited “real life evidences, particularly from UK”.
The decision, according to members of India’s Covid Working Group that recommended it, was driven by studies that suggested that the first dose of the vaccine, developed by Oxford University and the British-Swedish company AstraZeneca, provided substantial protection. ....

United Kingdom , Jayaprakash Muliyil , Gagandeep Kang , Jacob John , Rakesh Agarwal , Anurag Agarwal , Council Of Scientific , India Working Group , Indian Council Of Medical Research , Institute Of Genomics , Jawaharlal Institute Of Postgraduate Medical Education , Public Health England On , Research In Puducherry , Public Health England , Oxford University , Industrial Research , India Covid Working Group , Covid Working Group , Working Group , British Medical Journal , Jawaharlal Institute , Postgraduate Medical Education , Health England , Indian Council , Medical Research , Integrative Biology ,